Doros Platika
Chief Executive Officer presso Supercentenarian Research Foundation
Profilo
Doros Platika is currently the President & Chief Executive Officer at the Supercentenarian Research Foundation and a Director at WorldCare, Inc. He previously served as President & Chief Executive Officer at Curis, Inc., Ontogeny, Inc., Centagenetix, Inc., and Pittsburgh Life Sciences Green House.
He was also a Director at V.I.
Technologies, Inc. and Cohera Medical, Inc. In addition, he held the position of Executive Vice President-Research & Development at Progenitor, Inc. Dr. Platika received his undergraduate degree from The Reed Institute and his doctorate from Stony Brook University.
Posizioni attive di Doros Platika
| Società | Posizione | Inizio |
|---|---|---|
| Supercentenarian Research Foundation | Chief Executive Officer | - |
WorldCare, Inc. (Massachusetts)
 WorldCare, Inc. (Massachusetts) Medical/Nursing ServicesHealth Services WorldCare, Inc. develops and commercializes global healthcare services and solutions. The firm’s services include worldcare ACCESS, worldcare ALLY, worldcare TRAVELER, worldcareMD, worldcare CONCIERGE, worldcare expert medical resources, worldcare consulting and management. The company was founded in 1996 and is headquartered in Boston, MA. | Director/Board Member | - |
Precedenti posizioni note di Doros Platika
| Società | Posizione | Fine |
|---|---|---|
V.I. Technologies, Inc.
 V.I. Technologies, Inc. BiotechnologyHealth Technology Vitex is a Delaware Corporation incorporated in 1995. Vitex’s scientific and clinical programs originated in anti-infective technologies designed to prevent the spread of infectious disease by blood transfusions. In March of 2005, Vitex merged with Panacos Pharmaceuticals, a private company developing HIV therapeutics with novel mechanisms of action. The merger with Panacos immediately expanded the Vitex pipeline into novel, high value therapeutics. The Panacos team that joined Vitex is recognized for fundamental contributions to HIV biology and drug development | Director/Board Member | 11/03/2005 |
| CURIS, INC. | Chief Executive Officer | 01/09/2001 |
Progenitor, Inc.
 Progenitor, Inc. BiotechnologyHealth Technology Progenitor, Inc. is an American private company. The firm develops pharmaceutical compounds for nervous system. The company is headquartered in Columbus, OH. | Chief Tech/Sci/R&D Officer | - |
Ontogeny, Inc.
 Ontogeny, Inc. BiotechnologyHealth Technology Ontogeny, Inc., located in Cambridge, Massachusetts whose mission is to become the preeminent biopharmaceutical company focused on translating developmental biology insights into regenerative medicine therapies that will significantly improve the quality of life by activating the body's ability to repair and regenerate, or to specifically control abnormal and malignant growth. The Company is developing therapeutics for neurological diseases including Parkinson's and Alzheimer's diseases, diabetes and dermatological disorders including skin cancer and hair growth. | President | - |
| Centagenetix, Inc. | President | - |
Formazione di Doros Platika
| The Reed Institute | Undergraduate Degree |
| Stony Brook University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CURIS, INC. | Health Technology |
| Aziende private | 8 |
|---|---|
Progenitor, Inc.
Progenitor, Inc. BiotechnologyHealth Technology Progenitor, Inc. is an American private company. The firm develops pharmaceutical compounds for nervous system. The company is headquartered in Columbus, OH. | Health Technology |
V.I. Technologies, Inc.
V.I. Technologies, Inc. BiotechnologyHealth Technology Vitex is a Delaware Corporation incorporated in 1995. Vitex’s scientific and clinical programs originated in anti-infective technologies designed to prevent the spread of infectious disease by blood transfusions. In March of 2005, Vitex merged with Panacos Pharmaceuticals, a private company developing HIV therapeutics with novel mechanisms of action. The merger with Panacos immediately expanded the Vitex pipeline into novel, high value therapeutics. The Panacos team that joined Vitex is recognized for fundamental contributions to HIV biology and drug development | Health Technology |
Cohera Medical, Inc.
 Cohera Medical, Inc. Medical SpecialtiesHealth Technology Cohera Medical, Inc. develops surgical adhesives and sealants. Its flagship product, TissuGlu, is an internal surgical adhesive used for large flap surgical operations like tummy tucks which lessens or even eliminates the accumulation of fluid and the need to undertake post surgical drains. The firm also offers Sylys Surgical Sealant, an adhesive that lessens anastomotic leakage in intestinal anastomosis procedures. The company was founded by Eric Beckman and Michael J. Buckley in 2006 and is headquartered in Raleigh, NC. | Health Technology |
Ontogeny, Inc.
Ontogeny, Inc. BiotechnologyHealth Technology Ontogeny, Inc., located in Cambridge, Massachusetts whose mission is to become the preeminent biopharmaceutical company focused on translating developmental biology insights into regenerative medicine therapies that will significantly improve the quality of life by activating the body's ability to repair and regenerate, or to specifically control abnormal and malignant growth. The Company is developing therapeutics for neurological diseases including Parkinson's and Alzheimer's diseases, diabetes and dermatological disorders including skin cancer and hair growth. | Health Technology |
| Centagenetix, Inc. | Commercial Services |
WorldCare, Inc. (Massachusetts)
WorldCare, Inc. (Massachusetts) Medical/Nursing ServicesHealth Services WorldCare, Inc. develops and commercializes global healthcare services and solutions. The firm’s services include worldcare ACCESS, worldcare ALLY, worldcare TRAVELER, worldcareMD, worldcare CONCIERGE, worldcare expert medical resources, worldcare consulting and management. The company was founded in 1996 and is headquartered in Boston, MA. | Health Services |
Pittsburgh Life Sciences Green House
 Pittsburgh Life Sciences Green House Investment ManagersFinance Pittsburgh Life Sciences Green House (PLSG) is a venture capital firm founded in 2002. The firm is headquartered in Pittsburgh, Pennsylvania. | Finance |
| Supercentenarian Research Foundation |
- Borsa valori
- Insiders
- Doros Platika
